SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sanofi Targets 70% of Tests Without Horseshoe Crab Blood by 2030

Sanofi aims to transition 70% of its tests away from horseshoe crab blood by 2030.

Related stories